SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Nuvectis Pharma to participate in upcoming investor conferences

Nuvectis Pharma said it will participate in upcoming investor conferences. The clinical-stage biopharmaceutical company focuses on complement-related conditions and oncology.

NVCT

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.

Related stories